Cargando…

Effects of a Long-Term Monitored Exercise Program on Aerobic Fitness in a Small Group of Children with Cystic Fibrosis

Background: The aim of this study was to investigate the effects of a monitored exercise program on aerobic fitness in children with cystic fibrosis (CF). Methods: Six children (2f/4m) with ages ranging from 6 to 14 years (11.3 ± 3.3 years.) and a mean ppFEV1 102.5 ± 13.5% pred. participated in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gruber, Wolfgang, Stehling, Florian, Blosch, Christopher, Dillenhoefer, Stefanie, Olivier, Margarete, Koerner-Rettberg, Cordula, Sutharsan, Sivagurunathan, Mellies, Uwe, Taube, Christian, Welsner, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265477/ https://www.ncbi.nlm.nih.gov/pubmed/35805585 http://dx.doi.org/10.3390/ijerph19137923

Ejemplares similares

Trainability of Health-Related and Motor Performance Fitness in Adults with Cystic Fibrosis within a 12-Month Partially Supervised Exercise Program
por: Welsner, Matthias, et al.
Publicado: (2021)

Long-Term Follow-Up of Health-Related Quality of Life and Short-Term Intervention with CFTR Modulator Therapy in Adults with Cystic Fibrosis: Evaluation of Changes over Several Years with or without 33 Weeks of CFTR Modulator Therapy
por: Gruber, Wolfgang, et al.
Publicado: (2023)

Barriers for Sports and Exercise Participation and Corresponding Barrier Management in Cystic Fibrosis
por: Dillenhoefer, Stefanie, et al.
Publicado: (2022)

Association between habitual physical activity (HPA) and sleep quality in patients with cystic fibrosis
por: Dietz-Terjung, Sarah, et al.
Publicado: (2020)

Association between habitual physical activity (HPA) and sleep quality in patients with cystic fibrosis
por: Dietz-Terjung, Sarah, et al.
Publicado: (2020)

Changes in Clinical Markers During A Short-Term Transfer Program of Adult Cystic Fibrosis Patients from Pediatric to Adult Care
por: Welsner, Matthias, et al.
Publicado: (2019)

How personality influences health outcomes and quality of life in adult patients with cystic fibrosis
por: Niehammer, Ute, et al.
Publicado: (2023)

Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis
por: Olivier, Margarete, et al.
Publicado: (2023)

Cough suppression and HRQoL in adult people with cystic fibrosis: an unexplored correlation
por: Niehammer, Ute, et al.
Publicado: (2022)

Use of ivacaftor in late diagnosed cystic fibrosis monozygotic twins heterozygous for F508del and R117H-7T – a case report
por: Welsner, Matthias, et al.
Publicado: (2019)

Investigation of respiratory rate in patients with cystic fibrosis using a minimal-impact biomotion system
por: Straßburg, Svenja, et al.
Publicado: (2022)

Obstructive sleep apnea and nocturnal hypoxemia in adult patients with cystic fibrosis
por: Welsner, Matthias, et al.
Publicado: (2022)

Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry
por: Sutharsan, Sivagurunathan, et al.
Publicado: (2023)

An 8 week open-label interventional multicenter study to explore the lung clearance index as endpoint for clinical trials in cystic fibrosis patients ≥8 years of age, chronically infected with Pseudomonas aeruginosa
por: Sutharsan, Sivagurunathan, et al.
Publicado: (2020)

Regulatory T cell enhancement in adults with cystic fibrosis receiving Elexacaftor/Tezacaftor/Ivacaftor therapy
por: Westhölter, Dirk, et al.
Publicado: (2023)

Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy
por: Koerner-Rettberg, Cordula, et al.
Publicado: (2014)

Bacteraemia and fungaemia in cystic fibrosis patients with febrile pulmonary exacerbation: a prospective observational study
por: Grosse-Onnebrink, Joerg, et al.
Publicado: (2017)

Species-Specific Interferon-Gamma Release Assay for the Diagnosis of Mycobacterium abscessus Complex Infection
por: Steindor, Mathis, et al.
Publicado: (2021)

Glomerular and Tubular Renal Function after Repeated Once-Daily Tobramycin Courses in Cystic Fibrosis Patients
por: Stehling, Florian, et al.
Publicado: (2017)

Coil embolisation for massive haemoptysis in cystic fibrosis
por: Dohna, Martha, et al.
Publicado: (2021)

Reduced Lung Function in a Chronic Asthma Model Is Associated with Prolonged Inflammation, but Independent of Peribronchial Fibrosis
por: Koerner-Rettberg, Cordula, et al.
Publicado: (2008)

Factors Associated with Worse Lung Function in Cystic Fibrosis Patients with Persistent Staphylococcus aureus
por: Junge, Sibylle, et al.
Publicado: (2016)

Multiplex PCR of bronchoalveolar lavage fluid in children enhances the rate of pathogen detection
por: Tschiedel, Eva, et al.
Publicado: (2019)

Bronchial artery diameter in massive hemoptysis in cystic fibrosis
por: Dohna, Martha, et al.
Publicado: (2022)

Relationship between daily physical activity and aerobic fitness in adults with cystic fibrosis
por: Savi, Daniela, et al.
Publicado: (2015)

Normal reference values for aerobic fitness in cystic fibrosis: a scoping review
por: Tomlinson, Owen W, et al.
Publicado: (2022)

Biofilm infection of a central venous port-catheter caused by Mycobacterium avium complex in an immunocompetent child with cystic fibrosis
por: Kavvalou, Alexandra, et al.
Publicado: (2022)

High Variability in Oral Glucose Tolerance among 1,128 Patients with Cystic Fibrosis: A Multicenter Screening Study
por: Scheuing, Nicole, et al.
Publicado: (2014)

Effects of chest physiotherapy and aerobic exercise training on physical fitness in young children with cystic fibrosis
por: Elbasan, Bulent, et al.
Publicado: (2012)

A multi-centre, randomized, controlled trial on coaching and telemonitoring in patients with cystic fibrosis: conneCT CF
por: Thee, Stephanie, et al.
Publicado: (2021)

Efficacy and safety of inhaled ENaC inhibitor BI 1265162 in patients with cystic fibrosis: BALANCE-CF 1, a randomised, phase II study
por: Goss, Christopher H., et al.
Publicado: (2022)

Tezacaftor/ivacaftor in people with cystic fibrosis who stopped lumacaftor/ivacaftor due to respiratory adverse events
por: Schwarz, Carsten, et al.
Publicado: (2021)

Cardiopulmonary responses to maximal aerobic exercise in patients with cystic fibrosis
por: Williams, Craig A., et al.
Publicado: (2019)

The Effect of Dysglycaemia on Changes in Pulmonary and Aerobic Function in Cystic Fibrosis
por: Tomlinson, Owen W., et al.
Publicado: (2022)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Comparison of different analysis algorithms to calculate multiple-breath washout outcomes
por: Anagnostopoulou, Pinelopi, et al.
Publicado: (2018)

Quality of life is associated with physical activity and fitness in cystic fibrosis
por: Hebestreit, Helge, et al.
Publicado: (2014)

Cardiorespiratory fitness on a treadmill in an adult cystic fibrosis population
por: Torvanger, Ole, et al.
Publicado: (2020)

Skeletal muscle contributions to reduced fitness in cystic fibrosis youth
por: Tomlinson, Owen William, et al.
Publicado: (2023)

Serum KL-6 as a Candidate Predictor of Outcome in Patients with SARS-CoV-2 Pneumonia
por: Kattner, Simone, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_urg249c9253013pdk0a7mqaitd